-
公开(公告)号:US20220265753A1
公开(公告)日:2022-08-25
申请号:US17744872
申请日:2022-05-16
发明人: Young Bae RYU , Sang Woo Lee , Sang Ho Choi , Ji Young Park , Hyung Jun Kwon , In Chul Lee , Jong Sub Lee , Woo Song Lee , Wan Yi Li
IPC分类号: A61K36/60 , A23L33/105 , A61P5/24
摘要: The present invention relates to a method of preventing or alleviating symptoms of andropause comprising administering a pharmaceutically effective amount of an extract of Ficus auriculata Lour. To a patient in need thereof. The extract of Ficus auriculata Lour. of the present invention exhibits the effect of preventing and alleviating erectile dysfunction by inhibiting the activity of PDE5, and the effect of preventing and alleviating prostatic hyperplasia by suppressing the expression of AR and PSA.
-
公开(公告)号:US20180027843A1
公开(公告)日:2018-02-01
申请号:US15547229
申请日:2016-01-28
发明人: Woo Song Lee , Hyung Jae Jeong , Mun Chual Rho , Young Bae Ryu , Hyung Jun Kwon , Su Jin Park , Ji Young Park
IPC分类号: A23K20/10
摘要: The present invention relates to a composition for removing an amine-based compound, comprising an oleoresin turmeric extract, a fraction thereof, or water-soluble curcumin, a licorice extract or a fraction thereof, and a salmon milt extract as an active ingredient; and a composition for feed and feed additive comprising the same. The composition of the present invention can reduce an amine-based compound such as ammonia in animal excrement that causes the odor, and thereby reduce the odor caused by the amine-based compound and provide an effect of improving a feeding environment.
-
3.
公开(公告)号:US20240285557A1
公开(公告)日:2024-08-29
申请号:US18572480
申请日:2022-06-24
申请人: INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY , KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
发明人: Kyoung Oh CHO , Tae ll JEON , Sun Woo LEE , Yeong Bin BAEK , Hyung Jun Kwon , Hueng Sik CHOI , Sang lk PARK , Muhammad SHARIF , Jeong Ah LIM
IPC分类号: A61K31/17 , A61K31/215 , A61K31/675 , A61P31/14 , A61P31/16
CPC分类号: A61K31/17 , A61K31/215 , A61K31/675 , A61P31/14 , A61P31/16
摘要: The present invention relates to a therapeutic agent of a lipase inhibitor for a wide spectrum of RNA viral infections in humans and animals. More specifically, the lipase inhibitor can be used as a therapeutic agent for influenza A virus infection, bovine coronavirus infection, porcine epidemic diarrhea coronavirus infection, bovine rotavirus infection, porcine reproductive and respiratory syndrome virus infection, and sapoviral infection and furthermore, can be utilized as a therapeutic agent for various RNA viral infections in humans and animals, such as infections with SARS COV-1, MERS-COV, Zika virus, dengue fever virus, and hepatitis A and C viruses.
-
-